Evidence map›Paper›PMID 37224315›Full record

ArticleWellcome open research2021

Rapid viral metagenomics using SMART-9N amplification and nanopore sequencing.

Ingra M Claro, Mariana S Ramundo, Thais M Coletti, Camila A M da Silva, Ian N Valenca, Darlan S Candido, Flavia C S Sales, Erika R Manuli, Jaqueline G de Jesus, Anderson de Paula and 12 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Detection of a novel ShamondaEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Yellow fever virus resurgence in Sao Paulo State, Brazil, 2024-2025.Revista do Instituto de Medicina Tropical de Sao Paulo · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Metagenomics enables the first detection ofFrontiers in systems biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 3 countries.

Ingra M ClaroFaculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0001-8637-2910
Mariana S RamundoInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0002-0650-4985
Thais M ColettiInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0003-1693-7984
Camila A M da SilvaInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0002-4298-6782
Ian N ValencaInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0001-6614-2755
Darlan S CandidoMRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, SW7 2AZ, UK.
Flavia C S SalesFaculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0002-9048-0030
Erika R ManuliInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
Jaqueline G de JesusMRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, SW7 2AZ, UK.ORCID https://orcid.org/0000-0002-5404-272X
Anderson de PaulaInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
Alvina Clara FelixInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
Pamela Dos Santos AndradeInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
Mariana C PinhoInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
William M SouzaWorld Reference Center for Emerging Viruses and Arboviruses and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, 77555, USA.ORCID https://orcid.org/0000-0002-0025-8293
Mariene R AmorimLaboratory of Emerging Viruses, Department of Genetics, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, 13083-862, Brazil.
José Luiz Proenca-ModenaLaboratory of Emerging Viruses, Department of Genetics, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, 13083-862, Brazil.
Esper G KallasFaculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
José Eduardo LeviInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.
Nuno Rodrigues FariaMRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London, SW7 2AZ, UK.ORCID https://orcid.org/0000-0002-9747-8822
Ester C SabinoInstituto de Medicina Tropical, Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, 05403-000, Brazil.ORCID https://orcid.org/0000-0003-2623-5126
Nicholas J LomanSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK.ORCID https://orcid.org/0000-0002-9843-8988
Joshua QuickSchool of Biosciences, University of Birmingham, Birmingham, B15 2TT, UK.
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRUniversity of Liverpool · GBUniversidade Estadual de Campinas (UNICAMP) · BRUniversity of Birmingham · GBThe University of Texas Medical Branch at Galveston · USUniversidade de São Paulo · BR

Funding

World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)R24AI120942 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2016 to 2024
$8.5M
Medical Research Council MR/S019510/1NIAID NIH HHS R24 AI120942Wellcome Trust
6 · The paper itself

Abstract

Emerging and re-emerging viruses are a global health concern. Genome sequencing as an approach for monitoring circulating viruses is currently hampered by complex and expensive methods. Untargeted, metagenomic nanopore sequencing can provide genomic information to identify pathogens, prepare for or even prevent outbreaks. SMART (Switching Mechanism at the 5' end of RNA Template) is a popular approach for RNA-Seq but most current methods rely on oligo-dT priming to target polyadenylated mRNA molecules. We have developed two random primed SMART-Seq approaches, a sequencing agnostic approach 'SMART-9N' and a version compatible rapid adapters  available from Oxford Nanopore Technologies 'Rapid SMART-9N'. The methods were developed using viral isolates, clinical samples, and compared to a gold-standard amplicon-based method. From a Zika virus isolate the SMART-9N approach recovered 10kb of the 10.8kb RNA genome in a single nanopore read. We also obtained full genome coverage at a high depth coverage using the Rapid SMART-9N, which takes only 10 minutes and costs up to 45% less than other methods. We found the limits of detection of these methods to be 6 focus forming units (FFU)/mL with 99.02% and 87.58% genome coverage for SMART-9N and Rapid SMART-9N respectively. Yellow fever virus plasma samples and SARS-CoV-2 nasopharyngeal samples previously confirmed by RT-qPCR with a broad range of Ct-values were selected for validation. Both methods produced greater genome coverage when compared to the multiplex PCR approach and we obtained the longest single read of this study (18.5 kb) with a SARS-CoV-2 clinical sample, 60% of the virus genome using the Rapid SMART-9N method. This work demonstrates that SMART-9N and Rapid SMART-9N are sensitive, low input, and long-read compatible alternatives for RNA virus detection and genome sequencing and Rapid SMART-9N improves the cost, time, and complexity of laboratory work.

Indexed as

diagnosticgenomic surveillancemetagenomicnanopore sequencingRNA virusSARS-CoV-2YFVZIKV

Identifiers

PMID37224315
PMCPMC10189296
OpenAlexW4366826938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.